Cooper Companies Inc (NYSE:COO) – Investment analysts at KeyCorp reduced their Q1 2018 earnings estimates for shares of Cooper Companies in a research report issued to clients and investors on Friday. KeyCorp analyst M. Mishan now expects that the medical device company will post earnings of $2.32 per share for the quarter, down from their previous estimate of $2.63. KeyCorp currently has a “Hold” rating on the stock. KeyCorp also issued estimates for Cooper Companies’ Q2 2018 earnings at $3.06 EPS, Q3 2018 earnings at $3.02 EPS and Q4 2018 earnings at $3.11 EPS.
Cooper Companies (NYSE:COO) last issued its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.64 by $0.01. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. The company had revenue of $561.50 million for the quarter, compared to analyst estimates of $558.86 million. During the same period in the prior year, the firm earned $2.28 earnings per share. The business’s revenue for the quarter was up 8.3% compared to the same quarter last year.
Cooper Companies (COO) traded up $1.89 during mid-day trading on Monday, hitting $228.45. 774,200 shares of the company were exchanged, compared to its average volume of 427,958. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.41 and a quick ratio of 1.26. Cooper Companies has a 12-month low of $169.39 and a 12-month high of $256.39. The stock has a market capitalization of $11,089.94, a price-to-earnings ratio of 23.31, a price-to-earnings-growth ratio of 1.83 and a beta of 0.54.
In other news, Director Gary S. Petersmeyer sold 3,977 shares of the stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $244.94, for a total value of $974,126.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.60% of the company’s stock.
A number of institutional investors have recently added to or reduced their stakes in the business. ProVise Management Group LLC lifted its holdings in Cooper Companies by 0.6% in the second quarter. ProVise Management Group LLC now owns 1,177 shares of the medical device company’s stock valued at $282,000 after acquiring an additional 7 shares during the period. YorkBridge Wealth Partners LLC increased its position in shares of Cooper Companies by 2.1% in the second quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock valued at $126,000 after buying an additional 11 shares in the last quarter. Wedbush Securities Inc. increased its position in shares of Cooper Companies by 1.0% in the second quarter. Wedbush Securities Inc. now owns 1,783 shares of the medical device company’s stock valued at $427,000 after buying an additional 18 shares in the last quarter. Sentry Investment Management LLC increased its position in shares of Cooper Companies by 0.7% in the second quarter. Sentry Investment Management LLC now owns 2,801 shares of the medical device company’s stock valued at $671,000 after buying an additional 19 shares in the last quarter. Finally, Suntrust Banks Inc. increased its position in shares of Cooper Companies by 0.6% in the second quarter. Suntrust Banks Inc. now owns 6,616 shares of the medical device company’s stock valued at $1,583,000 after buying an additional 40 shares in the last quarter. 96.79% of the stock is owned by institutional investors.
About Cooper Companies
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.